EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The effects of cannabidiol and its main metabolites on human neural stem cells

Leah E Latham, Qiang Gu, Shuliang Liu, Cheng Wang, Fang Liu

Experimental Biology and Medicine · 2025

DOI: 10.3389/ebm.2025.10608 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Biology and Medicine, 2025. Verfasst von Leah E Latham und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurotoxicology, National Center for Toxicological Research/Food and Drug Administration, Jefferson, AR, United States. Hauptthemen laut MEDLINE: Cannabidiol, Neural Stem Cells. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cannabidiol (CBD) has been used for different purposes by different populations in recent years. When consumed by pregnant women, CBD can pass through the placenta and enter the fetal blood stream. There is concern over adverse effects of fetal exposure to CBD and its major metabolites (7-OH-CBD and 7-COOH-CBD). In the present study, human neural stem cells (NSCs) were treated with CBD and its metabolites at different concentrations for various durations to understand how the drug may affect fetal brain development. NSCs were also treated with delta-9 tetrahydrocannabinol (THC) for comparison purposes. CBD, 7-OH-CBD and 7-COOH-CBD dose-dependently reduced NSC viability. CBD and 7-OH-CBD reduced NSC number at the G1 phase. A 24 h exposure did not cause significant change in NSC proliferation. At concentrations comparable to those detected in human blood, longer exposures to CBD, 7-OH-CBD and 7-COOH-CBD caused more obvious cell death. After NSCs differentiation, CBD treatment reduced GFAP and cannabinoid receptor 2 (CB2) expression. THC treatment reduced the GFAP expression, but the change in CB2 expression did not reach statistical significance. The expression of cannabinoid receptor 1 (CB1) and beta-tubulin III were not significantly altered by drug exposures. The study demonstrated that clinically relevant concentrations of CBD, 7-OH-CBD and 7-COOH-CBD affect basic physiological features of human NSCs. After NSC differentiation, the reduced expression of CB2 receptors and GFAP on differentiated cells further indicated the vulnerability of developing central nervous system to CBD and THC. These data will help to contextualize in vivo neurodevelopmental studies that may not accurately model human metabolite profiles of CBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabidiolNeural Stem CellsHumansCell ProliferationCell DifferentiationCell SurvivalDronabinolCells, CulturedReceptor, Cannabinoid, CB2

Stichwörter der Autor:innen

7-COOH-CBD7-OH-CBDCBDTHCneural stem cells

Substanzen

CannabidiolDronabinolReceptor, Cannabinoid, CB2

Autor:innen und Institutionen

  • Division of Neurotoxicology, National Center for Toxicological Research/Food and Drug Administration, Jefferson, AR, United States.

Zitieren

APA

Latham, L. E., Gu, Q., Liu, S., Wang, C., & Liu, F. (2025). The effects of cannabidiol and its main metabolites on human neural stem cells. Experimental Biology and Medicine. https://doi.org/10.3389/ebm.2025.10608

Vancouver

Latham LE, Gu Q, Liu S, Wang C, Liu F. The effects of cannabidiol and its main metabolites on human neural stem cells. Experimental Biology and Medicine. 2025. doi:10.3389/ebm.2025.10608

BibTeX
@article{Latham2025,
  author = {Latham, Leah E and Gu, Qiang and Liu, Shuliang and Wang, Cheng and Liu, Fang},
  title = {The effects of cannabidiol and its main metabolites on human neural stem cells},
  journal = {Experimental Biology and Medicine},
  year = {2025},
  doi = {10.3389/ebm.2025.10608}
}
Kostenlos starten →